80407-64-3

Basic information

• Product Name: 3,4-bis(2-Methoxyethoxy)benzaldehyde
• Synonyms: 3,4-bis(2-Methoxyethoxy)benzaldehyde;Erlotinib Impurity 33
• CAS NO: 80407-64-3
• Molecular Formula: C₁₃H₁₈O₅
• Molecular Weight: 254.27902
• EINECS: 1308068-626-2
• Mol File: 80407-64-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 380.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.115±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3,4-bis(2-Methoxyethoxy)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-bis(2-Methoxyethoxy)benzaldehyde(80407-64-3)
• EPA Substance Registry System: 3,4-bis(2-Methoxyethoxy)benzaldehyde(80407-64-3)

Safety Data

• Hazardous Substances Data: 80407-64-3(Hazardous Substances Data)

Usage

General Description

3,4-bis(2-Methoxyethoxy)benzaldehyde is an aromatic compound with the molecular formula C14H18O5. As suggested by its name, the compound features a benzaldehyde core, which is a benzene ring attached to the aldehyde functional group. This core is then further substituted at the 3 and 4 positions by two methoxyethoxy groups. This chemical has uses in the production of various polymer materials, as these types of compounds often serve as building blocks or reactive intermediates in the creation of polymers. However, specific information about its safety, toxicity, or environmental impact may not be readily available.

Upstream product

• 121-33-5 vanillin 
• 4296-15-5 2-iodo-1-methoxyethane 
• 139-85-5 3,4-dihydroxybenzaldehyde 
• 36865-41-5 3-bromopropanol methyl ether 
• 627-42-9 2-chloroethyl methyl ether 

Downstream Products

• 1006377-63-4 C₁₃H₁₉NO₅ 
• 1175086-56-2 3,4-bis-(2-methoxy-ethoxy)-benzylamine 
• 819813-71-3 3,4-bis(2-methoxyethoxy)-benzoic acid 
• 179688-14-3 methyl 3,4-bis{[2-(methyloxy)ethyl]oxy}benzoate 
• 501684-22-6 methyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate 
• 476168-17-9 2-amino-4,5-bis-(2-methoxyethoxy)-benzoic acid methyl ester 
• 236750-62-2 2-amino-4,5-bis[(2-methoxy)ethoxy]benzamide 
• 1172625-04-5 4,5-bis(2-methoxyethoxy)-2-nitrobenzamide 
• 1387641-12-4 3-{[6,7-Bis-(2-methoxy-ethoxy)-2-oxo-1,2-dihydro-quinoline-3-carbonyl]-amino}-4-methyl-benzoic acid methyl ester 
• 1384975-87-4 4,5-bis-(2-methoxy-ethoxy)-2-nitro-benzaldehyde 
• 183319-69-9 erlotinib hydrochloride 
• 183322-18-1 4-chloro-6,7-bis(2-methoxyethoxy)quinazoline 
• 236750-65-5 4,5-bis(2-methoxyethoxy)-2-nitrobenzonitrile 
• 80407-68-7 3,4-bis(2-methoxyethoxy)-benzonitrile 

Relevant articles and documents

The influence of polyether substituents on biological activity of curcumin derivatives

Curcumin is reported as an anti-proliferative and chemopreventive compound. However, it shows poor water solubility, low bioavailability, and rapid metabolism. To address these problems, curcumin derivatives substituted with polyether chain were synthesiz

Styryl xanthine derivatives and uses thereof (by machine translation)

The invention discloses styryl xanthine derivatives and application, and particularly, relates to a novel styryl xanthine derivative and a pharmaceutical composition containing the same, and can be used as selective adenosine A. 2A Are antagoni

CARBOXYLIC ACID ARYL AMIDES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.